Tectonic Therapeutic | AVRO - Umsatzerlöse





Der Umsatz Veränderung Datum
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.29B 120M 2026-06
Celltrion KRW 1.24T 90B 2026-06
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 27.58B 730M 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
Ionis Pharmaceuticals USD 268M 22M 2026-06
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
MacroGenics USD 20.8M 20.43M 2026-03
Medical Developments International AUD 21.57M 12.04M 2025-12
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 59.79M 3.74M 2026-03
Pfizer USD 15.03B 530M 2026-06
Pharma Mar EUR 50M 7.1M 2026-06
Qiagen NV USD 463.12M 43.9M 2026-06
Roche Holding CHF 30.36B 14.71B 2026-06
Sangamo BioSciences USD 356K 125K 2024-06
Sanofi EUR 11.95B 710M 2026-06
Sarepta Therapeutics USD 401.3M 329.5M 2026-06
Sartorius EUR 911.8M 12.7M 2026-06
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Takeda JPY 1.22T 130B 2026-06
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 34M 34.92M 2026-03
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M 2026-03